Planning and Reporting. 4.1 The Company will provide CRT with a Development Plan within [***] of the Licence Grant Date, and will comply with the then current Development Plan at all times. The Company will notify CRT in writing of amendments to the Development Plan within [***] of the amendments being made. 4.2 The Company will provide CRT with written progress reports, each in a form and with the detail reasonably requested by CRT, which describes the activities performed by or on behalf of the Company: 4.2.1 under the then current Development Plan; 4.2.2 to develop each Licensed Product; and 4.2.3 where pending, to obtain Regulatory Authorisations and Price Approvals. The Company will provide the first written progress report before the [***] anniversary of the Licence Grant Date, and at least every [***] afterwards, or at least every [***] throughout any period in which section 4.4.2 of these Licence Terms applies. 4.3 The Company will notify CRT in writing of the occurrence of each Milestone Event within [***] after its occurrence. 4.4 If, before the First Commercial Sale in the United Kingdom, the Company undergoes a change of Control, or begins (whether alone or with a third party) or acquires a Competing Programme, the Company will: 4.4.1 notify CRT in writing within [***] of the change of Control or its commencement or acquisition of the Competing Programme; and 4.4.2 for [***] after the change of Control or commencement or acquisition of the Competing Programme, provide a written progress report as required under section 4.2 at least every [***].
Appears in 2 contracts
Sources: Clinical Trial and Option Agreement (Vaccitech PLC), Clinical Trial and Option Agreement (Vaccitech LTD)